COVID-19 VACCINE SAFETY AND EFFECTIVENESS

Clinical trial NCT05133609 · UNKNOWN

Trial details

NCT number: NCT05133609
Sponsor: Federal University of Espirito Santo
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2021-01-15
Primary completion: 2022-08-01
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.